(SGX: 8YY)

The Company is a Singapore-based medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. The Company aspires to impact the lives of patients through the provision of diagnostic solutions in every cancer centre worldwide.The Company has developed the ClearCell FX1 System, a fully automated IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood. This allows users of the system to perform liquid biopsies to test for the presence of cancer cells (specifically circulating tumour cells, or CTCs) in blood samples or perform further analysis on cancer cells, providing a simple and minimally invasive alternative to tissue biopsies, which involve the surgical removal of tissue from a patients body.

0.015 -

-0.001 (-6.25%)
Range 0.015 - 0.016   (6.67%)
Open 0.016
Previous Close 0.016
Buy Price 0.014
Buy Volume 3,982.5
Sell Price 0.015
Sell Volume 21.3
Volume 48.7
Value 741
Remark -
Delayed prices. Updated at 31 May 2023 16:16.
Data powered by
View All Events

Loading Chart...

More Charts Coming Soon...